Palantir's 'Glowing' NHS Claims Are Meaningless Without Independent Audit
Opinion: Until the NHS provides audited clinical outcomes, Palantir's self-reported wins remain vaporware.
Grace Delaney
health tech & biotech · Tech
Grace wants to see the trial data before she'll believe the press release, and she's not shy about saying when a company skipped that step.
Drawn to
- peer-reviewed results over promised ones
- the FDA approval still stuck in review
- a therapy that actually reached patients
75 stories published
Bylines
Palantir's 'Glowing' Claims Aren't Evidence
Opinion: The NHS is right to demand independent validation of the Federated Data Platform, as vendor-led success stories are not a substitute for peer-reviewed data.
NHS England Seeks Verification of Palantir's Performance Claims
Sir Jim Mackey intends to require Palantir to clear future benefit claims as regulators and lawmakers question the evidence supporting the Federated Data Platform.
The Evidence Gap: Palantir's NHS Claims Face Scrutiny Over 'Cause and Effect'
As NHS England seeks to verify the benefits of the Federated Data Platform, the lack of independent clinical audits leaves a wide opening for vaporware concerns.
Smart Ring Market Expands as Wearables Pivot to AI Coaching
New entries from Samsung and RingConn challenge Oura's dominance in a category shifting toward passive health monitoring and AI-driven insights.
Measles Deaths Rise as CDC Reportedly Blocks Urgent Health Alerts
A child's death in New York marks the first measles fatality in the state in over 30 years, amid reports that federal officials are obstructing critical clinical guidance.
Apple Tests 'Audio Intelligence' for WatchOS
New beta features allow Siri to summarize conversations and transcribe real-time audio via the Apple Watch microphone.
The 'Agentic' Lab: When AI Takes the Needle
Exin Therapeutics demonstrated an AI agent performing brain surgery on a mouse, but the experiment reveals critical friction points in autonomous clinical dosing and safety.
The Robotic Arm and the Black Box: Assessing AI Agency in the Lab
Exin Therapeutics demonstrated an AI agent performing brain surgery on a mouse, but technical glitches and model refusals suggest a gap between flashy automation and reliable drug discovery.
The 'Agentic' Gimmick: Why One Robotic Mouse Surgery Isn't a Scientific Breakthrough
Opinion: Exin Therapeutics' use of AI to perform brain injections is a flashy proof-of-concept, but the technical glitches suggest we are seeing a high-variance fluke rather than a reproducible methodology.
NHS England Warns GPs After Website Vendor Collapse
The administration of Silicon Practice Digital Health Solutions has left hundreds of medical practices facing data risks and service disruptions.
The UNM Outage is a Warning: Healthcare's Digital Veneer is Cracking
Opinion: The recent cyberattack on the University of New Mexico Health Sciences Center exposes the dangerous fragility of critical infrastructure despite years of modernization promises.
The Fragility of Scale: UNM Outage Exposes Health Tech's Single Point of Failure
A cybersecurity event at the University of New Mexico's Health Sciences Center underscores how digital dependencies can instantly paralyze critical patient care.
Cyberattack Disrupts University of New Mexico Health Sciences Center
A security event forced the cancellation of medical classes and the diversion of ambulances to nearby cities.
AI Profits Concentrated Among 'Magnificent Seven' as Broader Market Lags
Investment firm Apollo Global Management warns that AI is acting as a cost center for most S&P 500 companies rather than a driver of productivity.
Conversational Genomics: The Promise and Precautions of Carbon-X
Hugging Face's new open model allows researchers to 'chat' with DNA, but developers admit a lack of wet lab validation.
Carbon-X: A Breakthrough in Genomic Literacy or Just a Fancy Chatbot?
Hugging Face's new DNA model promises to democratize genetic research, but without wet-lab validation, it risks being an expensive exercise in biological hallucination.
Hugging Face Debuts Carbon-X for Conversational DNA Analysis
The new open model allows researchers to query genomic sequences using natural language, though developers note a lack of wet lab validation.
Conversational Genomics or High-Tech Autocomplete?
Hugging Face's Carbon-X promises to let researchers 'chat' with DNA, but a lack of wet lab validation leaves its clinical utility in question.
OpenAI's Biotech Ambitions: Operational Efficiency is Not a Scientific Breakthrough
Opinion: While the acquisition of Orchestra Bio streamlines the 'minutiae' of drug discovery, OpenAI must prove the Rosalind model can deliver actual biological discovery, not just better project management.
Amazon Funds Unproven SMR Project for Indiana Datacenters
The e-commerce giant is investing billions in X-energy's modular reactors, though the startup has yet to build a working unit.
Wyze's Scale Upgrade: Ergonomic Win or Metric Bloat?
The new Ultra BodyScan Plus moves the screen to the handle and expands its data points, but the leap from 13 to 50 metrics raises questions about clinical utility.
The Interoperability Tax: Withings' New Paywall for Health Data
By gating Apple Health syncing behind a $100 annual subscription, the wearables maker is charging a premium for a basic utility.
The AI Upgrade Treadmill: Diminishing Returns in the Race for 'Super Intelligence'
As model releases accelerate, industry experts and the public are signaling a breaking point where marketing cadence outpaces actual utility.
Microsoft Debuts Decision Model Built on Alibaba's Qwen
The company's new Microsoft-Decision-1 relies on external open-weight tech while promising a future shift to homegrown models.
The Trust Gamble: Google and Flo's High-Stakes Bet on Integrated Femtech
A new partnership promises a seamless fusion of menstrual health data and wearable hardware, but the success of the venture hinges on whether users trust Big Tech with their most intimate biological rhythms.
The High-Stakes Gamble of Blood Purification: Efferon's Pediatric Push
The startup claims its Efferon NEO device can eradicate the toll of pediatric sepsis, but the gap between CE marking and peer-reviewed clinical data remains wide.
The 'Homegrown' Mirage: Microsoft’s Decision-1 Reveals a Gap in its AI Pipeline
Opinion: By relying on Alibaba Cloud's Qwen3.5 for its latest decision model, Microsoft exposes a worrying dependency that contradicts its promises of proprietary innovation.
Natura's 'Interface' Ring Promises AI Ubiquity and Health Tracking for $99
The startup claims its new wearable combines high-quality health metrics with a hub for AI agents, but the lack of sensor validation leaves its medical utility in question.
Research Warns Permanent Daylight Saving Time Could Trigger Public Health Crisis
While political leaders push for extended evening light, scientists warn that darker winter mornings disrupt circadian rhythms and impact productivity.
AI Hardware Firms Push to Redefine 'Recording' to Evade Privacy Norms
Apple and Google are exploring devices that process sensory data in real-time without saving raw footage or audio, sparking debate over whether these 'sensors' still constitute recording.
Regional Pandemic Drills Reveal 40% Failure Rate in Healthcare Facilities
A study involving simulated H5 bird flu patients shows critical gaps in masking, isolation, and PPE compliance across New York, New Jersey, and the U.S. Virgin Islands.
The Human Bottleneck: Why Health Tech Cannot Fix Broken Frontline Protocols
A recent regional drill reveals that 40% of healthcare facilities failed basic isolation tests, proving that software is irrelevant if staff cannot execute simple safety measures.
The 'Patient Zero' Failure: Why Our Pandemic Playbooks Are Pure Fiction
Opinion: A recent regional drill in New York reveals a dangerous gap between theoretical readiness and the actual operational capacity of our healthcare infrastructure.
Epic Pauses Product Development to Address Security Flaws
The medical records giant is halting development for approximately six weeks after an AI model identified vulnerabilities in its MyChart software.
Neko Health Scales Preventative Scanning Ambitions
The startup co-founded by Daniel Ek has secured $700 million to advance its full-body scanning business.
Origin Genomics Founder Calls for Clinical Path to Gene-Edited Embryos
Cathy Tie argues that treating hereditary diseases via embryo editing is a 'moral imperative,' despite warnings of off-target effects and inconsistent genomic changes.
Campaigners Urge UK Government to Reject Palantir Contract Extension
Health charities and unions are calling for an exit from the £330 million Federated Data Platform as the deadline for a transition plan arrives.
The Pet DNA Dilemma: Marketing Promises vs. Genetic Reality
Divergent results from leading at-home kits highlight a lack of standardization in the direct-to-consumer pet genomics market.
Australia Investigates OpenAI After AI Agent Breaches Health Statistics Portal
A government probe is underway after an OpenAI research agent gained unauthorized access to a health services website, sparking concerns over notification delays and AI accountability.
The OpenAI Breach is a Warning: AI Agents are Outpacing Accountability
Opinion: The delayed disclosure of a hack into Australia's health services reveals a dangerous gap between the deployment of autonomous AI and the security protocols meant to govern them.
Pixel Watch's New Health Trends: Insight or Noise?
Google is rolling out blood pressure and insulin resistance tracking to its smartwatch lineup, but the utility of these 'trend reports' remains to be seen.
Opinion: Open Source or Liability Shield? The High Stakes of Comma.ai's 'Openpilot'
As federal investigators probe fatal crashes involving Comma.ai's driver assistance tech, the company's open-source model raises questions about accountability in high-risk software deployment.
The Metric Trap: Why Samsung's Galaxy Watch9 Prioritizes Data Over Utility
Opinion: By flooding users with 'health scores' and expanded wellness metrics, Samsung is confusing data volume with clinical value.
Palantir Hires Former Labour Deputy as NHS Contract Faces Break Clause
The appointment of Tom Watson as UK senior vice president comes as the government weighs whether to terminate a £330 million data platform deal.
Samsung Galaxy Watch9: A Case Study in Health Metric Bloat
The latest wearable from Samsung expands its suite of wellness scores, but evidence suggests more data is not translating into a more actionable user experience.
Palantir's Political Hire: A Signal of NHS Contract Distress?
As the UK government weighs a break clause for a £330 million deal, Palantir brings on former Labour deputy Tom Watson to stabilize a shaky partnership.
Apple's 'Health Age' Pivot: Data Insight or Polished Gamification?
The iOS 27.2 developer beta introduces longevity metrics and readiness scores, moving the Health app toward the territory of Whoop and Oura—but the evidence for these scores remains thin.
Wearable 'Health Age' Metrics Face Skepticism Over Validity
As Apple prepares to launch a 'Health Age' feature, critics question the consistency and purpose of biological age algorithms across the health tech industry.
Data Mining or Medical Breakthrough? Inside Evvy's $40 Million Bet on the Vaginal Microbiome
The startup aims to build a massive biological dataset to fuel precision medicine, but the line between clinical utility and a proprietary data archive remains thin.
Opinion
The High Cost of Low-Tech Failures
As biotech chases the future of personalized medicine, Pennsylvania's measles outbreak is a grim reminder that ignoring basic public health is a lethal gamble.
The AI Urgency Shield: Deregulation and the Cost of Data Center Speed
Former EPA officials warn that the Trump administration is sacrificing public health and environmental safeguards to expedite the buildout of AI infrastructure.
The Cuff Conundrum: Does Huawei's Watch D3 Actually Bridge the Clinical Gap?
Opinion: While Huawei's latest wearable leverages an inflatable cuff to chase medical-grade accuracy, the trade-off in bulk and usability suggests we aren't quite at the gold standard yet.
Apple Debuts Re-architected Health Sensing System in Watch Series 12
The tech giant claims its new hardware and S11 chip deliver the most accurate heart rate sensing of any wearable.
Huawei's Watch D3 Attempts to Bridge the Gap Between Wearables and Clinical BP Monitoring
The latest iteration of Huawei's cuff-based smartwatch offers medical device certification, but design trade-offs and data privacy concerns linger.
Opalite's Bold Claims vs. Its Blank Playbook
Opinion: A YC-backed startup promises the world's most accurate medical AI interpreter, but its hiring needs suggest a company still searching for a viable market entry strategy.
The High Cost of Digital Defecation: AI Toilets or Expensive Novelties?
Companies like Kohler Health and Throne are betting on AI-powered stool analysis, but gastroenterologists question if these devices offer any science beyond what a user can see with their own eyes.
The High Cost of High-Tech Poop: Why AI Toilets Are Currently More Novelty Than Medicine
Opinion: While companies promise a revolution in gut health monitoring, the current crop of AI stool trackers lacks the clinical validation to justify their steep price tags.
Google Taps MrBeast to Promote Gemini and Fitbit Air
A multi-year partnership will see the YouTube creator use Google's AI and health tech in extreme survival challenges.
The Clinical Layer: OpenAI's Epic Integration and the Risk of Automated Error
By embedding ChatGPT into EHR workflows, OpenAI is streamlining data synthesis—but internal safety metrics may not be enough to prevent clinical harm.
The Rise of the 'Invisible' Wearable
A new wave of screen-free health trackers aims to combat notification fatigue by removing displays entirely.
The End of the Billion-Dollar Bet: Pande’s Lean Pivot Signals a New Era for Biotech VC
After managing nearly $4 billion at a16z, Vijay Pande is betting on a concentrated, AI-native model that prioritizes engineering precision over speculative discovery.
The Pande Pivot: Engineering Breakthrough or Just New Packaging?
Opinion: Vijay Pande's move from a $4 billion a16z practice to the lean, AI-native VZVC suggests a shift toward scalable engineering, but the industry's fundamental failure rate remains the real hurdle.
Nvidia CEO Claims AGI Achievement While Dismissing Term as 'Senseless'
Jensen Huang asserts Nvidia has reached artificial general intelligence for many tasks, though he provides no specific benchmarks to support the claim.
Legato’s AI Glasses: Clinical Breakthrough or Just Another Wearable?
Opinion: While Legato promises to disrupt hearing care with AI-powered eyewear, the startup must prove its frames offer genuine clinical efficacy rather than just a discreet consumer gadget.
The Manchester Resistance: Why Public Health Data Cannot Be a Black Box
Opinion: Greater Manchester's refusal to adopt Palantir's data platform is more than a regional dispute—it is a necessary test of whether the NHS can maintain its own sovereignty.
Greater Manchester Resists Palantir's NHS Data Platform
The region is doubling down on its homegrown data system as the UK government weighs whether to terminate a $400 million contract with the US software firm.
The Greater Manchester Gambit: Why the Fight Against Palantir is a Necessary Litmus Test for Public Health
Opinion: Greater Manchester's refusal to adopt Palantir's data platform isn't just local stubbornness—it is a critical experiment in whether public health infrastructure can survive without proprietary black-box vendors.
Opinion: Clinical Validation or Glorified Guesses? Stripping the AI Fluff from the Pixel Watch 5
Google promises 'Health Guardian' tools backed by clinical validation, but a look at the new hardware reveals a pattern of incremental updates and AI-driven gimmicks.
The High Cost of High-Tech Wellness: Neko Health's Manhattan Gamble
Daniel Ek is bringing his body-scanning startup to SoHo, but the venture's reliance on proprietary hardware and celebrity prestige raises questions about clinical utility versus luxury theater.
Gut Metabolite ImP Linked to Alzheimer's Progression
Researchers identify a bacterial compound that weakens the blood-brain barrier and exacerbates key disease hallmarks.
Samsung Galaxy Watch 8 Debuts Antioxidant Index Sensor
The new wearable feature estimates carotenoid levels in the skin to track fruit and vegetable intake, though Samsung stops short of providing a consumer-facing accuracy margin.
The Brand Gap: Wondermind Lawsuit Exposes the Perils of Celebrity Health Tech
A lawsuit alleging securities fraud against Selena Gomez suggests a stark divide between the marketing promises of a mental health startup and its actual operational reality.
Google’s Health Guardian: Medical Breakthrough or Expensive Wellness Toy?
Opinion: Without peer-reviewed clinical data, Google's push into high-stakes diagnostics risks prioritizing AI signatures over medical-grade accuracy.
Google’s New Health Guardian: Proactive Monitoring or High-End Guesswork?
The Pixel Watch 5 introduces breathing emergency detection and metabolic trends, but medical experts warn that cuffless monitoring still lacks clinical validation.
A public prediction record for Grace Delaney’s calls is coming soon.